ChinaDaily Briefs

Daily Brief China: BYD, Tianqi Lithium, Topsports International, Tencent, Huayiwang Technology and more

In today’s briefing:

  • BYD (1211 HK): Is Buffett Bailing?
  • Tianqi Lithium H Share Listing: Trading Debut
  • Topsports (6110 HK): Upsizing Undervalued Sporting Goods Play
  • BYD’s Shares Tumble Awaiting Berkshire’s Next Move
  • Topsports International Holdings – Is Cheap Enough to Counter Some of the Risks
  • Tencent/Netease: Under Pressure with No Game Approval in July
  • Tencent – Excluded Again from New Game Approvals
  • Topsports International (6110.HK) – Has the Potential to Turn Things Around Despite the Headwinds
  • Topsports International: CCP’s ZERO COVID Policy Has a Bigger Whopper Impact than Cheap Valuations
  • Pre-IPO Huayiwang Technology – The Business Model Is Reasonable, but There Are Also Challenges

BYD (1211 HK): Is Buffett Bailing?

By David Blennerhassett

  • Just days after BYD (1211 HK) surpassed Tesla Motors (TSLA US) as the world’s largest electric vehicle producer by sales, is Warren Buffet cashing in his chips?
  • 225mn shares of BYD  – 7.73% of the H shares – moved into CCASS yesterday. These are Berkshire Hathaway’s shares. 
  • For a shareholder who has kept his holding in share certificates for 13 years, this development suggests the possibility of a partial or full exit. 

Tianqi Lithium H Share Listing: Trading Debut

By Arun George

  • Tianqi Lithium (002466 CH) priced its H Share at HK$82.00 per share to raise net proceeds of HK$13,062 million (US$1.7 billion). The H Share will start trading tomorrow.
  • The H Share listing (HK$82.00) and grey market price (HK$76.50) imply an AH discount of 45% and 49%, respectively. This compares to Ganfeng Lithium (1772 HK)’s current 35.3% AH discount.
  • The relative valuation is attractive. At the H Share listing price, Tianqi Lithium (9696 HK)’s H Share trades at a -6% discount to the median peers’ CY2022 P/B multiple.

Topsports (6110 HK): Upsizing Undervalued Sporting Goods Play

By David Blennerhassett


BYD’s Shares Tumble Awaiting Berkshire’s Next Move

By Arun George

  • The increase of 225.2 million CCASS shares deposited with Citibank matches Berkshire Hathaway Inc Cl B (BRK/B US)’s stake. BYD (1211 HK) closed -12% down on speculation of a selldown.   
  • The H Share recently touched all-time highs and trades at a significant premium to historical multiples. BYD has a recent history of a selldown by a substantial shareholder (Himalaya Capital).
  • Berkshire has made a 33x gain on its BYD investment, excluding dividends. Taking money off the table would align with Berkshire’s value investing mandate.

Topsports International Holdings – Is Cheap Enough to Counter Some of the Risks

By Sumeet Singh

  • Topsports International Holdings (TIH) is now trading close to its all time lows, after the shares corrected by 50% over the past year.
  • The company is one of the largest retailers for Nike (NKE US) and Adidas AG (ADS GR) in China.
  • Given then on/off lockdowns the near term outlook isn’t great, but the stock appears cheap for those willing to take a longer view.

Tencent/Netease: Under Pressure with No Game Approval in July

By Ke Yan, CFA, FRM

  • China just announced game approval for July batch. More games were approved in July compared to June and May.
  • Pace of China game approval has picked up albeit at a much slower pace than pre-tightening.
  • Tencent and Netease will be under pressure as they continue to score zero in July domestic game approval. 

Tencent – Excluded Again from New Game Approvals

By Shifara Samsudeen, ACMA, CGMA

  • China’s NPPA issued a list of 67 new games approved for July 2022, and once again, Tencent (700 HK)  and its smaller rival NetEase were excluded from the list.
  • The nine-month long freeze on new game approval was lifted in April, however, none of Tencent’s new games were included in the approved lists in April, June and July.
  • This further affirms our view that the anti-monopoly crackdown on tech firms hasn’t slowed down, but regulators are probing on dominant players such as Tencent to level the playing field.

Topsports International (6110.HK) – Has the Potential to Turn Things Around Despite the Headwinds

By Xinyao (Criss) Wang

  • Topsports suffered the first decline in performance since FY2018. Besides pandemic outbreaks and inventory shortage due to global supply chain disruption, over-reliance on Nike and Adidas is also the reason.
  • This is the best opportunity to reduce the number of stores based on “Select+Optimize” strategy. With resumption of sports events and good prospects of China’s sports industry, Topsports could rebound.
  • Topsports is undervalued compared with its peers, but we are now in a complicated macro environment. Share prices may not rise as expected, which should be aware of by investors. 

Topsports International: CCP’s ZERO COVID Policy Has a Bigger Whopper Impact than Cheap Valuations

By Douglas Kim

  • One of the key reasons why we are bearish on this stock (despite cheap valuations) is that the valuations may become even cheaper. 
  • The CCP remains intent on maintaining its ZERO COVID policy which means continued sporadic lockdowns and social distancing measures, which is negative for sports apparel products.
  • All in all, we believe that a better time to get back into Topsports International is when the CCP becomes more vocal about finally relenting on its ZERO COVID policy. 

Pre-IPO Huayiwang Technology – The Business Model Is Reasonable, but There Are Also Challenges

By Xinyao (Criss) Wang

  • Huayiwang Technology (1985554D HK) is strong in its digital medical education solutions, which is the cornerstone business for the continuous expansion of other solution offerings and ecosystem.
  • HUAYIWANG charges service fees mainly from pharmaceutical companies, which could be a more sustainable profit model than charging from patients directly.
  • However, the increasing competition and potential risk of losing medical professionals could shake the foundations of HUAYIWANG’s business. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars